Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBM12B antisense RNA 1 (RBM12B-AS1)
- Target
- RBM12B-AS1
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
RBM12B antisense RNA 1 (RBM12B-AS1) is a non-coding RNA gene classified as a long non-coding RNA (lncRNA). It does not encode a protein and its functional role in human biology, if any, remains poorly understood and uncharacterized in the scientific literature. RBM12B-AS1 is listed with multiple aliases, including C8orf39 and PRO1905, but is distinct from the protein-coding gene RBM12 (RNA binding motif protein 12), which has a documented role as a post-transcriptional regulator of fetal hemoglobin. There are currently no drugs known to interact with RBM12B-AS1, it is not used as a biomarker, and it has not been implicated as a therapeutic target or disease gene. The lncRNA RBM12B-AS1 should not be confused with the protein-coding gene RBM12, which is a distinct gene involved in the regulation of hemoglobin switching and post-transcriptional mRNA regulation. No protein product or receptor function is attributed to RBM12B-AS1.
- Other names
- C8orf39PRO1905RBM12B antisense gene protein 1RBM12B antisense RNA 1 (non-protein coding)
Beyond the preview
Go deeper on RBM12B antisense RNA 1 (RBM12B-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RBM12B antisense RNA 1 (RBM12B-AS1).